Page 140 - CW E-Magazine (31-12-2024)
P. 140

Top Stories                                                                                                                                                                    Pharmaceuticals


       CHANGE OF PLANS                                                                                               EXPANSION

       Vedanta revises demerger proposal, retains base                                                               Lonza adding new capsule manufacturing lines

       metals undertaking                                                                                            at Haryana site


          Mumbai-listed mining conglome-  the ongoing search for alternative aven-  parts of the demerger scheme. All terms,   Lonza, the Swiss pharma CDMO,  tional  lines due to start operations in  Health  Ingredients,  said,  “Hard  gela-
       rate Vedanta Ltd. said it had revised its  ues for restarting the copper business in  including the share entitlement ratio,   has announced capacity  expansions  Q3 2025, the  additional  manufactur-  tine  capsules represent an important
       demerger proposal and decided to retain  Thoothukudi,  Tamil Nadu, an integral  remain  unchanged. Vedanta’s  Chairman   at  its  sites  in  Rewari,  Haryana  and  ing capacity  aims to enhance  Lonza’s  pharmaceutical  dosage form that is
       the base metals undertaking within the  part of the Base Metals undertaking, as  Mr. Anil Agarwal had earlier said the pro-  Suzhou (China). The expansions include  Capsules  &  Health  Ingredients  (CHI)  well tolerated  by patients  and consu-
       parent fi rm.                      the reason behind the development.  posed demerger of the company’s diverse   additional hard gelatine capsule (HGC)  business offering to meet regional  mers thanks to the ease of swallowing
                                                                          verticals, which represent more than 15    lines to support the manufacture  of  market demand and drive technology  and better taste and odour masking.
          In  a  regulatory  fi ling, Vedanta  said   The non-implementation of the  commodities, will see it progress from   high-quality hard  gelatine capsules,  upgrades.            Thanks to their favourable dissolution
       the decision was taken following deli-  demerger of the Base Metals undertaking  asset managers to asset owners.  including essential and specialised                             rates, these capsules are valuable  for
       berations with stakeholders, including  and its retention in  Vedanta will not                                capsules for the pharmaceutical  and   The highly automated state-of-the-  developers of medicines and nutraceu-
       lenders, regarding  the scheme  and  impact the overall value creation for   After  receiving a  nod  from  lenders,   nutraceutical industries.   art manufacturing lines support the  ticals. With the additional lines at our
       approval by the board of directors in a  shareholders.             the diversifi ed natural resources company                                    production of capsules of various sizes  sites in India and China, we are scaling
       recent meeting.                                                    moved to the NCLT, seeking a demerger         HGCs  represent  highly  functional  and colours, and operate  under strin-  our offering and capacity to enable the
                                           “A demerger of the  Vedanta Base  and had expressed hopes of completing   and versatile capsules that can support  gent raw material and product control  success of our customer’s innovative
          The company had earlier said its  Metals undertaking may be considered  the process by the end of this fi scal year.   various applications across the pharma-  standards.      solutions and medicines in APAC. By
       existing businesses would be structured  at a stage when the  Base Metals  busi-  Vedanta had received approval  from   ceutical and  nutraceutical markets                       enhancing our manufacturing capabili-
       into six independent companies after the  ness evolves and matures to realise the  75% of secured creditors for its proposed   by  encapsulating  liquid  or  solid  fi lls.   Commenting  on the development,  ties, we aim to provide even greater
       demerger: Vedanta Aluminium, Vedanta  full value potential of such demerger for  business demerger.           With lines at Rewari and Suzhou sites  Ms. Aanchal  Tomar, APAC  Regional  fl exibility and reliability in meeting the
       Oil & Gas,  Vedanta Power,  Vedanta  shareholders,” the fi ling said.                                          operational  since Q4  2024 and addi-  Business Unit Head, Lonza Capsules &  needs of our partners.”
       Steel  and  Ferrous  Materials,  Vedanta                              The demerger will help simplify
       Base Metals, and Vedanta Ltd.       The shareholders will continue to  the company’s corporate structure by
                                         benefi t from unlocking value in the Base  creating independent businesses. More-
          “Lenders believe the scheme would  Metals business as part of residual Vedanta  over, it will offer global investors direct
       be more favourable for unlocking value  while also receiving equivalent shares  investment opportunities in pure-play
       and overall optimal balancing of debt  in the resulting companies.  The share-  companies linked to the country’s
       allocation across residual  Vedanta and  holders’ benefi cial interests in the overall  impressive growth.  The demerger will
       resulting companies if the Vedanta Base  value of Vedanta and resulting companies  allow the individual units to pursue
       Metals  undertaking  is  retained  in  re-  will remain unaffected, it said.  strategic agendas more freely and better
       sidual Vedanta itself,” the company said                           align with customers, investment cycles,
       in the latest fi ling.Vedanta also stressed   The revision will not impact the  and end markets.               REGULATORY ACTION
                                                                                                                     US-FDA restricts imports of some Viatris drugs made
       UPL in Dow Jones Sustainability Indices for second                                                            at Indore facility


       consecutive year                                                                                                 Viatris, the US-based generics fi rm  company said, without disclosing the  for four products,  Viatris said.  There
                                                                                                                     formed by the merger of Mylan and  specifi cs of the warning.        could be potential for additional excep-
          UPL  Ltd. has  announced  that  it  company statement. UPL’s recognition  (ESG)  performance. The  DJSI World   Upjohn, said the US Food and Drug                              tions based on further discussions with
       been ranked as the top agrochemi-  by DJSI is based on the company’s  Index highlights the top 10% of lead-   Administration  (FDA) has restricted   The 11 products will no longer be  the FDA. Viatris said its response to the
       cals company in the 2024 Dow Jones  performance in achieving the highest  ing global companies in each indus-  imports of 11 products made at the  accepted into the US until the warning  warning letter and import alert would
       Sustainability Indices (DJSI) for the  scores in the agrochemical sector in  try,  refl ecting  their  commitment  to   fi rm’s  facility  in  India  after  the  regu-  letter is lifted,  Viatris said in a state-  be submitted within the required time
       second year running, and achieved the  the S&P Global 2024 Corporate Sus-  promoting sustainable development.   lator’s inspection found it had violated  ment. It was not immediately clear  periods. The company said it had imme-
       fourth highest score globally in the  tainability Assessment (CSA).  In addition, the DJSI Emerging           federal requirements.             which products were affected.  The  diately implemented a remediation plan
       chemicals industry. “This marks the                                Markets Index honours the top 10% of                                         drugmaker said the facility makes oral  at the site and that necessary corrective
       second consecutive year that UPL has   The DJSI is a globally renowned  the largest 800 companies in emerging    The FDA has issued a warning letter  fi nished doses such as tablets and cap-  and preventive actions were underway.
       been included in both the DJSI World  benchmark for evaluating companies’  markets, selected for their outstanding   to Viatris  related  to its manufacturing  sules.  Due  to shortage concerns,  the  It also engaged independent third-party
       and Emerging Markets Indices,” said a  Environment, Social, and Governance  ESG practices.                    facility in Indore, Madhya Pradesh, the  agency has made conditional exceptions  experts to support the remediation plan.


       140                                                                 Chemical Weekly  December 31, 2024        Chemical Weekly  December 31, 2024                                                              141


                                      Contents    Index to Advertisers    Index to Products Advertised
   135   136   137   138   139   140   141   142   143   144   145